Health

AI integration into healthcare management systems is expected to reduce administration workflows, freeing practitioner time to dedicated to patients.

Restructuring efforts in major health tech firms continue. We revisit the 2023 North America Health Tech 200, highlighting the region's most promising startups in the health technology sector.

Governments are tightening regulations surrounding nutrition and supplements and are seeking means to improve enforcement efficiencies, evidenced by the upcoming US FDA reorganization.

A novel approach for treating atrial fibrillation, pulsed-field ablation employs electrical pulses to target and impair heart cells, presenting various potential benefits compared to conventional thermal ablation methods.

The worsening health outcomes in developing nations are being exacerbated by climate change. Resource limitations in these regions hinder the ability to manage outbreaks and maintain adequate living conditions.

Declining birth rates result from a complex combination of factors, with rising infertility rates in developed nations being a key contributor.

Facing a global shortage of radiologists and pathologists, healthcare systems are increasingly adopting AI-powered diagnostic solutions to meet the rising demand for diagnostic services. This technology aids human specialists, offering the potential to decrease errors and enhance outcomes.

Artificial intelligence is quickly revolutionizing the healthcare sector, with a wide range of applications emerging in different fields. Recent advancements are bolstering this trajectory.

Precision medicine is increasingly defining healthcare strategies, with a focus on customizing treatment plans for individual patients. These modifications could offer valuable insights for earlier diagnoses or preventive actions in at-risk individuals.

Value-based care shifts reimbursement towards outcomes, incentivizing quality, population health management, and cost reduction through financial metrics for sustainable, optimal healthcare results.

Recent innovations in the genomic landscape have allowed for more cost-effective sequencing options. However, the same scalability is yet to be seen for gene therapies.

The global diabetic patient population is projected to rise significantly, with expectations of a twofold increase in Africa from 2021 to 2045.